Vortex Pharma Solution ApS: Financial statements 2022
CVR: 43009672
Source: annual report 2022, Danish Business Authority
26/01/2022 – 31/12/2022
Vortex Pharma Solution ApS (CVR 43009672) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 319,114 and a net result of DKK 173,285. Equity in the 2022 report amounted to DKK 213,285. The solvency ratio was 46.9%.
- Gross Profit
- DKK 319,114
- Profit/Loss
- DKK 173,285
- Equity
- DKK 213,285
- Total Assets
- DKK 455,207
- Employees
- 0
Official annual report
Keep an eye on Vortex Pharma Solution ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of January 26, 2022, Flavia Christina Ladwig Robles is registered as adm. dir. of Vortex Pharma Solution ApS.
As of January 26, 2022, Vortex Holdings ApS is registered as an owner of Vortex Pharma Solution ApS with an ownership share of 100%.
Vortex Pharma Solution ApS was founded on January 26, 2022.
About Vortex Pharma Solution ApS
Vortex Pharma Solution ApS is a Danish company of the type Anpartsselskab based in Bagsværd, founded in 2022. The company is registered under the industry Anden teknisk rådgivning. The management consists of Flavia Christina Ladwig Robles. The company is owned by Vortex Holdings ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 255,541 and a net result of DKK -34,561 compared with DKK 302,635 the year before. Equity in the 2025 report amounted to DKK 111,433.